- Home
- CIG vs AXSM Comparison
CIG vs AXSM Comparison
Compare CIG & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIG
- AXSM
- Stock Information
- Founded
- CIG 1952
- AXSM 2012
- Country
- CIG Brazil
- AXSM United States
- Employees
- CIG N/A
- AXSM N/A
- Industry
- CIG Electric Utilities: Central
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- CIG Utilities
- AXSM Health Care
- Exchange
- CIG Nasdaq
- AXSM Nasdaq
- Market Cap
- CIG 5.7B
- AXSM 4.7B
- IPO Year
- CIG N/A
- AXSM 2015
- Fundamental
- Price
- CIG $1.90
- AXSM $90.73
- Analyst Decision
- CIG
- AXSM Strong Buy
- Analyst Count
- CIG 0
- AXSM 14
- Target Price
- CIG N/A
- AXSM $125.93
- AVG Volume (30 Days)
- CIG 3.1M
- AXSM 499.7K
- Earning Date
- CIG 11-13-2024
- AXSM 02-18-2025
- Dividend Yield
- CIG 16.19%
- AXSM N/A
- EPS Growth
- CIG 51.48
- AXSM N/A
- EPS
- CIG 0.51
- AXSM N/A
- Revenue
- CIG $7,088,707,319.00
- AXSM $338,457,000.00
- Revenue This Year
- CIG $0.58
- AXSM $44.89
- Revenue Next Year
- CIG $6.91
- AXSM $68.41
- P/E Ratio
- CIG $4.05
- AXSM N/A
- Revenue Growth
- CIG 5.33
- AXSM 51.47
- 52 Week Low
- CIG $1.69
- AXSM $64.11
- 52 Week High
- CIG $2.19
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- CIG 47.95
- AXSM 42.16
- Support Level
- CIG $1.75
- AXSM $89.09
- Resistance Level
- CIG $1.91
- AXSM $94.64
- Average True Range (ATR)
- CIG 0.05
- AXSM 3.64
- MACD
- CIG -0.01
- AXSM -1.14
- Stochastic Oscillator
- CIG 63.04
- AXSM 20.64
About CIG Comp En De Mn Cemig ADS
Cia Energetica DE Minas Gerais - Cemig Formerly Energy Company of Minas Gerais is a Brazilian power company that generates, transmits, and distributes electricity. As one of the largest power companies in Brazil, the firm operates across most Brazilian states and Chile. The company has various subsidiaries and operates chiefly through its generation, transmission, distribution, and gas segments. The majority of the company's revenue is derived from electricity sales to consumers. The company generates power primarily through hydroelectric resources and secondarily through thermal and wind resources.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.